These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7171971)

  • 81. Approach to screening and diagnosis in colorectal cancer.
    Winawer SJ; Sherlock P
    Semin Oncol; 1976 Dec; 3(4):387-97. PubMed ID: 793015
    [No Abstract]   [Full Text] [Related]  

  • 82. [Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].
    Koornstra JJ; Røkke O; Halvorsen JF; Haug K; Ogreid D
    Tidsskr Nor Laegeforen; 1995 Oct; 115(26):3266-70. PubMed ID: 7482456
    [TBL] [Abstract][Full Text] [Related]  

  • 83. How do we detect hereditary large bowel cancer? Biochemical diagnosis.
    Schwartz MK
    Prog Clin Biol Res; 1983; 115():123-9. PubMed ID: 6856628
    [No Abstract]   [Full Text] [Related]  

  • 84. Peroxidase levels in food: relevance to colorectal cancer screening.
    Caligiore P; Macrae FA; St John DJ; Rayner LJ; Legge JW
    Am J Clin Nutr; 1982 Jun; 35(6):1487-9. PubMed ID: 7081130
    [No Abstract]   [Full Text] [Related]  

  • 85. [Occult blood in feces--a prospective study for the comparison of Hemoccult and Fecatest].
    Beretta KR; Güller R; Singeisen M; Stalder GA
    Schweiz Med Wochenschr; 1978 Dec; 108(48):1905-7. PubMed ID: 715431
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Blood in feces. A screening method for early discovery of colorectal cancer].
    Kewenter J
    Lakartidningen; 1994 Mar; 91(9):803-4. PubMed ID: 8139343
    [No Abstract]   [Full Text] [Related]  

  • 87. Accuracy and value of the Hemoccult test in symptomatic patients.
    Leicester RJ; Lightfoot A; Millar J; Colin-Jones DG; Hunt RH
    Br Med J (Clin Res Ed); 1983 Feb; 286(6366):673-4. PubMed ID: 6402198
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gastrointestinal blood loss from a new buffered aspirin (Ostoprin): measurement by radiochromium and Hemoquant techniques.
    Lynch NM; McHutchison JG; Young GP; Deacon M; St John DJ; Barraclough D
    Aust N Z J Med; 1989 Apr; 19(2):89-96. PubMed ID: 2788406
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Participation in faecal occult blood screening for colorectal cancer.
    Dent OF; Bartrop R; Goulston KJ; Chapuis PH
    Soc Sci Med; 1983; 17(1):17-23. PubMed ID: 6844949
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Population-based colorectal cancer screening: Interval cancers and relationship with the quantitative faecal immunological for hemoglobin.
    Burón A; Macià F; Andreu M; Pellisé M; Castells X; Grau J
    Med Clin (Barc); 2019 Apr; 152(8):303-306. PubMed ID: 30146355
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Colorectal cancer: knowledge and attitude of surgeons in New Zealand.
    Isbister WH; Dent O
    Aust N Z J Surg; 1986 May; 56(5):399-403. PubMed ID: 3459450
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Measurement of occult upper gastrointestinal tract blood loss: a direct comparison of radiochromium and haem-porphyrin assay techniques.
    Young GP; St John DJ; Lynch NM; McHutchison JG; Barraclough D
    J Gastroenterol Hepatol; 1993; 8(4):328-33. PubMed ID: 8374088
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Change towards earlier stage at presentation of colorectal cancer.
    Robinson MH; Thomas WM; Hardcastle JD; Chamberlain J; Mangham CM
    Br J Surg; 1993 Dec; 80(12):1610-2. PubMed ID: 8298940
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Enteric alpha-1-antitrypsin loss and comparison with Okokit II and Haemoccult for the detection of colorectal cancer.
    Moran A; Hendrickse C; Jones AF; Neoptolemos J
    Surg Oncol; 1994 Jun; 3(3):147-51. PubMed ID: 7952398
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Assessment of Fecatest and Haemoccult for faecal occult blood testing.
    Barrison IG; Parkins RA
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1356. PubMed ID: 6812709
    [No Abstract]   [Full Text] [Related]  

  • 96. Diflunisal versus aspirin: a comparative study of their effect of faecal blood loss, in the presence and absence of alcohol.
    De Schepper PJ; Tjandramaga TB; Verhaest L; Daurio C; Steelman SL
    Curr Med Res Opin; 1978; 5(7):520-4. PubMed ID: 699626
    [TBL] [Abstract][Full Text] [Related]  

  • 97. 1,300 mg of aspirin daily does not cause positive fecal hemoccult tests.
    Norfleet RG
    J Clin Gastroenterol; 1983 Apr; 5(2):123-5. PubMed ID: 6304182
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Detection of silent colon cancer in routine examination.
    Greegor DH
    CA Cancer J Clin; 1969; 19(6):330-7. PubMed ID: 4983009
    [No Abstract]   [Full Text] [Related]  

  • 99. Faecal occult blood screening for patients with gastrointestinal symptoms.
    Falkson CB; Bates T
    Br J Surg; 1993 Oct; 80(10):1326. PubMed ID: 8242313
    [No Abstract]   [Full Text] [Related]  

  • 100. Patient compliance with self-directed Hemoccult testing.
    Morrow GR; Way J; Hoagland AC; Cooper R
    Prev Med; 1982 Sep; 11(5):512-20. PubMed ID: 7156061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.